Editorial
Pharmacy, like many other health care professions, has been adopting efforts to improve the coordination of care between patient care settings with the goal of reducing hospital readmissions and improving health outcomes. Many medicationrelated initiatives have focused on improving individual components of the patient care process-often limited to improving the accuracy of the medication list. While this is important, the majority of pharmacy-related initiatives have stopped short of tackling the transitions of care problem holistically with a patient-centered approach aimed at optimizing medication management and improving health outcomes. At a time when the profession is facing changes to its traditional product-focused identity, having pharmacists provide patient-focused, holistic, comprehensive clinical services aimed at improving transitions of care may help demonstrate a transformation in the culture of pharmacy to a service-focused identity.
A primary focus on a holistic view of medication management stands in contrast to the traditional and ongoing emphasis on medication distribution. While medication dispensing is still an important role, it is in a state of transition as advances in computerized physician order entry and pharmacist-technician directed verification programs are all promising to greatly reduce the need for pharmacists in the distribution process. This transition will lead to the reduction in the need for pharmacists unless the value of clinical services is clearly demonstrated. One way to demonstrate value is by taking a leadership role in preventing medicationrelated problems as patients transition through health care settings and home. Pharmacists have a unique patient-centered perspective, allowing them to balance the needs of multiple medical specialists prescribing medications to the same patient. They can help patients avoid or manage adverse effects that may impact adherence to therapy, therefore helping to ensure patients meet goals for care that maximizes their health care outcomes. By moving toward a more holistic and patient-centered clinical approach, pharmacists can position themselves to demonstrate an improvement in the safe and effective use of medications during error-prone care transitions.
While pharmacists are uniquely poised and trained to take on the challenge of improving medication management during transitions of care, one limitation is the failure of leadership and corporations to completely support and reward a culture of holistic patient care. For years, ever since the introduction of the concept of pharmaceutical care by Hepler and Strand, the pharmacy profession has identified strategies to provide clinical care to patients. Unfortunately, pharmacists often have distribution-related workload issues that supersede clinical care-for instance, community pharmacists may have quotas for the number of prescriptions filled during a shift. For most pharmacists, the clinical functions they participate in are task oriented and completed where the focus is on the medications rather than the patient. For example, adjusting dosing for patients with renal dysfunction on a few targeted drugs but not evaluating the rest of the patient's medication regimen for appropriate dosing or use in chronic kidney disease. This approach, which has been promoted by corporations and organizations who want to target some of the most critical medication-related problems, has not delivered on the full potential of clinical pharmacy care. In addition, this approach has meant that most patients have not been able to benefit from a comprehensive assessment of their entire medication regimen.
A pharmacist's involvement in care transitions is an opportunity to move beyond the task of obtaining an accurate medication list to fully evaluate the patient's medication regimen in context of the current and prior medical history. A comprehensive medication review should include an assessment of the efficacy and safety of all medications, interactions, appropriateness of dosing and dosage form, adherence, and a thorough evaluation of all acute and chronic treatment regimens with respect to optimizing patient outcomes. The goal of transitions of care is to make sure the medical management of the patient remains cohesive throughout changes in their care setting. It is natural that pharmacists, as the experts in the safe and effective use of medications, assume a leadership role in helping to assure that medication therapy optimizes patient outcomes while keeping the patient's goals and preferences as the focus. It is fair to say most pharmacy initiatives tackling transitions of care do not meet this standard. This may be because there is not yet full recognition of the value of this comprehensive pharmacist service-both in cost savings and patient outcome improvements. Medication management needs to be a primary component of clinical initiatives that also involve social and medical coordination.
Collaboration between hospital and community pharmacists is a way to facilitate the safe and effective use of medications during care transitions and on an ongoing longitudinal basis, but it is easier said than done. Sharing patient information is a major barrier during transitions because different patient care settings often do not have a natural communication channel such as a shared electronic health record. The concept of providing continuity during transitions of care is
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inherently complicated as it involves multiple clinicians in multiple settings. An additional challenge is establishing and maintaining the necessary relationships between clinicians to foster trust and interdisciplinary teamwork, in particular building bridges between inpatient and community pharmacists. Community pharmacists, as readily accessible health care providers, can provide comprehensive medication management services if they have access to relevant patient health information. One strategy to share patient information as they transition between hospital and community settings is through the development of a collaborative transition of care service where inpatient and outpatient pharmacists establish a network where the exchange of patient information is secure and meaningful. Embracing a collaborative practice between inpatient and community pharmacists with the goal of improving medication management during transitions of care is not only an excellent service that patients need but also a way of engaging all pharmacists in a comprehensive approach to patient care activities.
While the benefits to patients and to the pharmacy profession are undeniable, convincing leadership to embrace a vision of pharmacists as providers of comprehensive medication management to patients has several challenges. Success as holistic clinicians will depend upon a platform where pharmacists can demonstrate that their clinical activities can generate an improvement in the quality of health care provided and/or a cost savings. This is most powerfully demonstrated in reducing medication-related hospital admissions and improving patient-centered health outcomes. It will also depend upon strengthening the communication pathways between the disciplines both within and outside of hospitals. In addition, pharmacists may encounter resistance from physicians and other health care providers when they offer suggestions for improvement in medication management as these activities may be perceived as encroaching on the clinical responsibilities of others. Overcoming this culture in health care requires diplomacy and patience while building trust between disciplines.
In the current value-based reimbursement environment, pharmacists need to demonstrate the value of clinical services on several levels including a reduction in health care utilization, appropriate use of medications, and increased patient engagement. It is critical that pharmacists further explore how they will demonstrate the value of a comprehensive clinical approach. The value of these programs must be demonstrated in either an improvement in the quality of care or as saved dollars rather than billed dollars. The prospect of pharmacists billing as providers of clinical care is tantalizing, but is yet unrealized in legislation. If pharmacists want to be recognized as providers, clinicians, and expert medication consultants, they will have a higher hurdle to clear than other professions due to this issue with reimbursement for these services. Innovative strategies may help bridge the gap (for instance, capitalizing on International Classification of Diseases, 10th Edition [ICD-10] coding information to show a reduction in medication-related problems), but ultimately provider status would allow the most flexibility for pharmacists to assume a comprehensive clinical role.
Providing comprehensive clinical pharmacy care during care transitions can carve out a new niche within both hospital and community pharmacy settings and is an opportunity to demonstrate the value of holistic and patient-centered clinical pharmacy services. A pharmacy service that provides comprehensive medication management can also help pharmacists take a pivotal role in transitions of care, where medication errors contribute to poor outcomes. The provision of this service can greatly benefit all of the other health care providers who are involved in assuring the patient navigates care transitions successfully by providing the security of pharmacist oversight regardless of the number of specialists involved in the patient's care. Pharmacy should embrace the transition from a focus on medication distribution to a focus on our expertise in patient-centered medication management, and participating in transitions of care management can be vital to achieving this. This cultural change within the profession is the first step needed to become the holistic health care providers we are trained to be. 
